| Project/Area Number |
22591739
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Anesthesiology/Resuscitation studies
|
|---|
| Research Institution | Oita University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKATANI Juniji 大分大学, 医学部, 助教 (50537107)
OKUDA Kentaro 大分大学, 医学部, 講師 (60284808)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | 抗酸化物質 / 亜急性疼痛 / 鎮痛効果 / αリポ酸 / フリーラジカル / 疼痛管理学 / 抗酸化物 / 新規化合物DHLHZn |
|---|
| Research Abstract |
It was found that fewer side effects where use adjuvant-induced pain model in the rat, was administered subcutaneously daily to DHLHZN. Because that withdrawal latency by plantar test increased, infiltration of inflammatory cells was inhibited, the tissue MPO(Myeloperoxidase) concentration decreased, likely to have analgesic effect of DHLHZN by anti-inflammatory action was suggested. Next, we examined DHLHZN whether having an analgesic effect in dose-dependency, whether having an analgesic effect in after the administration subcutaneously, but was not proven.
|
